In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jafra to sell Zirh

This article was originally published in The Rose Sheet

Executive Summary

Exclusive men's skin-care and fragrance products from Zirh will be sold through direct seller's more than 500,000 beauty consultants under long-term development and distribution agreement, according to recent release. Deal "not only allows Zirh to substantially increase its sales through an alternative, profitable channel, but exposes our product to consumers who may not have had the opportunity to previously try them," Brian Robinson, president of Zirh Holdings, says. Jafra notes it "is implementing substantial resources around increasing [Zirh] brand presence and impact in the U.S." First line to be sold through Jafra network will comprise eight skin-care SKUs developed in collaboration with Jafra R&D; line will launch internationally in July 2009, followed by U.S. launch in August. Juan Gomez will oversee the initiative as Jafra Project Manager, according to Zirh; prior to joining Zirh, Gomez spent 10 years at Avon and participated in development of Derek Jeter's Driven and U by Ungaro



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts